For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Klox Technologies Limited

USPTO Granted Patents = 44

CIPO Patents = 55

EPO Patents = 14

Trademarks = 7

Forward Citations = 378

Loading Chart...

Loading Chart...

42 inventors (with patents filed for the assignee):

Remigio Piergallini (41 out of 47 patents)

Nikolaos Loupis (40 out of 47 patents)

Francesco Bellini (16 out of 20 patents)

4. David Ohayon (5 out of 12 patents)

5. Lise Hébert (5 out of 9 patents)

6. Shipra Rastogi (4 out of 5 patents)

7. Éric DesRosiers (3 out of 3 patents)

8. Andreas Nikolis (2 out of 2 patents)

9. Andrea Spaterna (1 out of 5 patents)

10. Eric Desrosiers (1 out of 2 patents)

11. Joanna Jaworska (1 out of 1 patent)

12. Emmanuelle Devemy (1 out of 1 patent)

13. Abdellatif Chenite (1 out of 9 patents)

14. Kevin Wilkinson (1 out of 2 patents)

15. Giovanni Scapagnini (1 out of 3 patents)

Core Competencies:

Biophotonic Compositions

Phototherapy Devices

Skin Rejuvenation

Wound Healing Agents

Oral Disinfection

Tissue Filler Compositions

Oxidative Photoactivation

Teeth Whitening

Photoactivatable Fibers

Biofilm Disruption

Pigmented Lesion Treatment

Rosacea Treatment

44 patents: Sort by Forward Citations

1. 11691025 - Methods and compositions for reversing or mitigating skin aging (2023-07-04),

2. 11426463 - Compositions and methods for biophotonic bone reconstruction (2022-08-30),

3. 11421349 - Photoactivatable fibers and fabric media (2022-08-23),

4. D957659 - Hand held illumination device for phototherapy (2022-07-12),

5. 11331257 - Biophotonic compositions and methods for providing biophotonic treatment (2022-05-17),

6. 11324823 - Biophotonic materials and uses thereof (2022-05-10),

7. 11266685 - Silicone-based biophotonic compositions and uses thereof (2022-03-08),

8. 11219514 - Phototherapy devices and methods (2022-01-11),

9. 11207408 - Biophotonic compositions, methods, and kits for inhibiting and disrupting biofilms (2021-12-28),

10. 11141482 - Combination of an oxidant, a photosensitizer and a wound healing agent for oral disinfection and treatment of oral disease (2021-10-12),

11. 11135146 - Peroxide-less biophotonic compositions and methods (2021-10-05),

12. 11116841 - Biophotonic compositions, kits and methods (2021-09-14),

13. 11020609 - Methods and compositions for treatment of pigmented lesions (2021-06-01),

14. 10881736 - Biophotonic compositions comprising a chromophore and a gelling agent for treating wounds (2021-01-05),

15. 10772990 - Tissue filler compositions and methods of use (2020-09-15),

KLOX TECHNOLOGIES LIMITED is a global leader in the development and commercialization of innovative biophotonic technologies for healthcare applications. The company specializes in the development of advanced light-based therapies for a wide range of medical conditions, including wound care, skin rejuvenation, and pain management. KLOX's proprietary technology platform utilizes the power of light to trigger biological responses in cells, promoting healing and regeneration. With a commitment to scientific excellence and patient-centric solutions, KLOX is dedicated to improving patient outcomes and transforming healthcare delivery.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

44 Patents

#42 in Dublin

#67 in Ireland

#15,286 in the World

Dublin, Ireland

Klox Technologies Limited

Forward Citations = 378

42 inventors:

Remigio Piergallini (41 out of 47 patents)

Nikolaos Loupis (40 out of 47 patents)

Francesco Bellini (16 out of 20 patents)

4. David Ohayon (5 out of 12 patents)

5. Lise Hébert (5 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…